Search

everythinglearnresearchcommunity

for

Search:↓

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

EGFR inhibitors can cause unusual localized hair growth.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

PEG and keratin scaffolds can effectively deliver protein drugs by controlling release based on pH levels.

Setipiprant did not significantly improve hair growth in men with hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

CTP-543 is generally safe for treating alopecia areata.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

High doses of progesterone can reduce seizures in mice.

A woman's excessive hair growth around a leg ulcer was linked to a treatment with Prostaglandin E1 ointment.

Progesterone and its metabolites can prevent seizures without major side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Controlling transposable elements is crucial for successful tissue regeneration.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The hydrogel helps heal diabetic wounds by reducing infection and inflammation.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.